Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Reducing African Americans' Alzheimer's Disease Risk Through Exercise-Mild Cognitive Impairment Cohort
Authors not listed
Pennington Biomedical Research Center · 2021
Abstract
The RAATE-MCI proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. RAATE-MCI is a 52-week randomized controlled trial. 144 African American adults aged 60 and older will be recruited.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2021). Reducing African Americans' Alzheimer's Disease Risk Through Exercise-Mild Cognitive Impairment Cohort. <em>Pennington Biomedical Research Center</em>. https://clinicaltrials.gov/study/NCT04956549
Vancouver
Anonymous. Reducing African Americans' Alzheimer's Disease Risk Through Exercise-Mild Cognitive Impairment Cohort. Pennington Biomedical Research Center. 2021.
BibTeX
@misc{anon2021Reduci,
title = {Reducing African Americans' Alzheimer's Disease Risk Through Exercise-Mild Cognitive Impairment Cohort},
author = {Anonymous},
journal = {Pennington Biomedical Research Center},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pennington Biomedical Research Center 2019
Open access · US-GOV
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
Douglas Mental Health University Institute 2023
Open access · US-GOV
The Healthy Aging Brain Study: A Remote Behavioral Intervention to Enhance Physical Activity in Older Adults.
The Cleveland Clinic 2009
Open access · US-GOV
Neural Effects of Exercise, Cognitive, or Combined Training in AD At-Risk Elders
Jewish General Hospital 2019
Open access · US-GOV
Frailty in Community Dwelling Older Adults With Heart Failure
NVP Healthcare 2026
Open access · US-GOV
36-week, Single-center, Randomized, Double-blind, Parallel-design, Placebo-controlled Trial to Determine the Safety and Efficacy of NVP-NK4146 in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Nature Reviews Neurology 2010
Citation only